查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085556

女性用避孕藥市場：依產品類型、作用機制、最終用戶年齡及通路分類－2026-2032年全球市場預測

Female Contraceptive Market by Product Type, Mechanism, End User Age, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，女性用避孕藥市場規模將達到 295.5 億美元，複合年成長率為 8.16%。

主要市場統計數據
基準年 2025 170.6億美元
預計年份：2026年 184億美元
預測年份 2032 295.5億美元
複合年成長率 (%) 8.16%

介紹女性用避孕市場

女性用避孕市場是生殖健康的核心領域，包括荷爾蒙避孕藥、子宮內避孕器（IUD）、植入、避孕貼片、陰道環、屏障避孕法和事後緊急避孕藥。該市場的需求主要源於高所得國家和新興國家醫療保健系統中預防意外懷孕、維護孕產婦健康以及增強女性生殖自主權的需要。

女性用避孕市場發生變革性變化

女性用避孕領域正從單一的避孕方法轉向更廣泛的避孕選擇，包括長效避孕方法和以病人為中心的就醫模式。長效可逆避孕方法，例如子宮內避孕器和植入，因其降低用藥依從性負擔而持續受到臨床關注。同時，口服避孕藥因其普及性、可近性和成熟性的處方途徑仍然十分重要。

人工智慧對女性避孕的累積影響

人工智慧 (AI) 在女性避孕生態系統中扮演著日益重要的角色，尤其是在需求預測、庫存最佳化、不利事件預警和數位化病人參與。人工智慧驅動的分析功能使醫療保健提供者能夠識別停藥風險、提供用藥依從性提醒，並根據年齡、病歷、禁忌症和偏好客製化教育內容。

關於女性用避孕藥具的關鍵區域性見解

亞太地區擁有龐大的育齡人口，但獲得諮商和現代避孕方法的途徑卻各不相同。中國、印度、日本、韓國、澳洲和東協等市場在法律規範、保險報銷、都市區醫療服務可及性、醫療服務提供者能力以及文化偏好等方面存在顯著差異，這為價格適中的口服避孕藥以及由醫療專業人員提供的長效可逆避孕方法創造了機會。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

東協市場呈現出機會與挑戰並存的局面。醫療保健服務的可近性不斷提高、年輕人口的成長以及數位醫療的日益普及，都推動了對現代避孕方式的需求。儘管公共部門採購仍發揮重要作用，但私人藥局、診所和行動醫療管道正在擴大都市區避孕服務的覆蓋範圍，並有助於提高年輕消費者的避孕意識。

主要國家女性用避孕市場的關鍵洞察

在美國，避孕藥具的可及性受多種因素影響，包括保險覆蓋範圍、各省政策差異、遠端醫療、藥房服務以及一些突破性產品的出現，例如獲得FDA批准的非處方每日口服避孕藥。在加拿大，政府主導的醫療保健服務和省級服務模式備受重視。同時，墨西哥和巴西仍然是拉丁美洲的重要市場，在這些國家，避孕藥具的可負擔性、公共部門的覆蓋範圍以及藥房的便利性都對避孕藥具的使用率產生顯著影響。

為行業領導者提供的實用建議

產業領導者應優先考慮避孕選擇、價格可負擔性、安全資訊和供應穩定性。建構均衡的產品系列，包括口服避孕藥、事後緊急避孕藥、屏障避孕法和長效可逆避孕藥，並輔以清晰易懂的諮詢材料和醫學上準確的數位化教育，將有助於企業獲得競爭優勢。

調查方法

本執行摘要基於二手研究，參考了包括世界衛生組織、聯合國人口基金、聯合國兒童基金會、美國疾病控制與預防中心、各國衛生機構、同行評審文獻以及藥品監管機構在內的權威公共衛生和監管資訊來源的數據。分析重點檢驗的指標，例如避孕需求、避孕方法組成、取得障礙、政策變化、安全指南和醫療服務趨勢。

結論

隨著避孕選擇範圍的擴大、數位化管道的普及、政策改革的推進以及人們對安全性、可負擔性、隱私性和公平性的期望不斷提高，女性避孕市場正在不斷發展。成熟市場和新興市場都存在機遇，但成功的關鍵在於使產品與臨床證據、患者偏好、監管標準以及當地的實際情況相契合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章女性用避孕藥市場：依產品類型分類

  • 植入
  • 注射藥物
  • 避孕器
    • 銅子宮內避孕器
    • 釋放荷爾蒙的子宮內避孕器
  • 口服避孕藥
    • 複方藥片
      • 第一代
      • 第四代
      • 第二代
      • 第三代
    • 僅含黃體素的避孕藥

第8章：女性用避孕市場：依機制分類

  • 荷爾蒙系統
    • 複雜類型
    • 黃體素單藥治療
  • 非荷爾蒙類

第9章：女性用避孕藥具市場：依最終用戶年齡分類

  • 15-24歲
  • 25-34歲
  • 35-49歲

第10章：女性用避孕藥市場：依通路分類

  • 診所
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章女性用避孕藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章女性用避孕藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章女性用避孕藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Cipla Limited
  • HLL Lifecare Limited
  • Insud Pharma, SL
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals SA
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Ritex GmbH
  • Sanofi SA
  • Say It With A Condom, LLC
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Viatris Inc.
Product Code: MRR-4348D129FB2D

The Female Contraceptive Market is projected to grow by USD 29.55 billion at a CAGR of 8.16% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.06 billion
Estimated Year [2026] USD 18.40 billion
Forecast Year [2032] USD 29.55 billion
CAGR (%) 8.16%

Female Contraceptive Market Introduction

The female contraceptive market is a core pillar of reproductive health, spanning hormonal contraceptive pills, intrauterine devices, implants, injectables, patches, vaginal rings, barrier methods, and emergency contraception. Demand is underpinned by the need to prevent unintended pregnancy, support maternal health, and expand reproductive autonomy across high-income and emerging healthcare systems.

WHO reports that more than 1.1 billion women of reproductive age need family planning, and UNFPA has highlighted that hundreds of millions still have an unmet need for modern contraception. This gap makes product availability, counseling quality, affordability, safety, privacy, and method choice central competitive factors for manufacturers, distributors, healthcare providers, and public health programs.

Transformative Shifts in the Female Contraceptive Landscape

The female contraceptive landscape is shifting from one-size-fits-all contraception toward broader method choice, longer-acting options, and patient-centered access models. Long-acting reversible contraceptives, including IUDs and implants, continue to gain clinical attention because they reduce adherence burden, while oral contraceptives remain important due to familiarity, accessibility, and established prescribing pathways.

Policy and channel dynamics are equally transformative. Over-the-counter access to selected oral contraceptives, telehealth prescribing, pharmacy-based services, and direct-to-consumer digital platforms are changing how women obtain contraception. At the same time, safety monitoring, equity concerns, informed consent, and supply reliability are becoming decisive factors in procurement, prescribing confidence, and brand trust.

Cumulative Impact of AI on Female Contraception

Artificial intelligence is increasingly relevant to the female contraceptive ecosystem, particularly in demand planning, inventory optimization, adverse event signal detection, and digital patient engagement. AI-enabled analytics can help providers identify discontinuation risks, support adherence reminders, and tailor educational content by age, medical history, contraindications, and preference profile.

The cumulative impact is operational as much as clinical. Manufacturers can use AI to improve pharmacovigilance workflows and supply chain resilience, while payers and public programs can model access gaps at a community level. However, AI deployment must remain clinically governed, privacy-compliant, transparent, and bias-tested to avoid reinforcing disparities in reproductive healthcare.

Key Regional Insights for Female Contraceptives

Asia-Pacific combines large reproductive-age populations with uneven access to counseling and modern contraceptive methods. China, India, Japan, South Korea, Australia, and ASEAN markets differ widely in regulatory pathways, reimbursement, urban-rural access, provider capacity, and cultural preferences, creating opportunities for both affordable oral contraceptives and clinician-administered long-acting reversible contraceptives.

North America is characterized by high awareness, established prescribing infrastructure, and growing interest in pharmacy access and telehealth, while Europe benefits from national health systems, strong regulatory oversight, and mature reproductive health services. Latin America shows sustained demand for affordable modern contraception, with Brazil and Mexico serving as important access markets where public programs, pharmacies, and clinician counseling shape method uptake.

The Middle East and Africa remain highly heterogeneous. GCC countries are shaped by private healthcare growth, women's health investment, and physician-led decision-making, whereas many African markets continue to face unmet need, financing constraints, stockout risks, and last-mile distribution challenges. Across both regions, reliable supply, culturally competent counseling, trained providers, and public-private partnerships are critical access enablers.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets present a mixed opportunity profile, with rising healthcare access, young populations, and increasing digital health adoption supporting demand for modern contraception. Public sector procurement remains influential, while private pharmacies, clinics, and mobile health channels are expanding method availability in urban centers and improving awareness among younger consumers.

The GCC is driven by healthcare modernization, private-sector investment, and growing attention to women's wellness, although adoption patterns remain closely linked to cultural norms, physician guidance, and privacy expectations. The European Union offers a highly regulated and evidence-driven environment where reimbursement, pharmacovigilance, patient information standards, and national family planning policies shape market access.

BRICS countries provide scale and long-term demand potential because they include major population centers such as Brazil, Russia, India, China, and South Africa, with diverse public health priorities and manufacturing capabilities. G7 markets are generally mature, innovation-sensitive, and policy-driven, while NATO membership overlaps with many high-income markets where supply security, regulatory compliance, and public health preparedness influence procurement priorities.

Key Country Insights in the Female Contraceptive Market

In the United States, contraceptive access is shaped by insurance coverage, state-level policy variation, telehealth, pharmacy services, and the landmark availability of an FDA-approved over-the-counter daily oral contraceptive. Canada emphasizes publicly guided healthcare access and provincial delivery models, while Mexico and Brazil remain important Latin American markets where affordability, public sector availability, and pharmacy access strongly influence uptake.

The United Kingdom, Germany, France, Italy, and Spain benefit from established reproductive health systems, though access models differ by reimbursement rules, pharmacy roles, primary care capacity, and national guidance. Russia represents a distinct market with local prescribing patterns, regulatory considerations, and healthcare delivery factors that affect product mix and patient access.

China and India anchor Asia's contraceptive volume potential, with demand influenced by demographics, public health programs, domestic manufacturing, private healthcare expansion, and urban-rural disparities. Japan, South Korea, and Australia are more mature healthcare markets where clinical guidance, safety perception, reimbursement, and women's health awareness influence adoption of pills, IUDs, implants, injectables, and emergency contraception.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize method choice, affordability, safety communication, and continuity of supply. Competitive advantage will come from portfolios that balance oral contraceptives, emergency contraception, barrier methods, and long-acting reversible methods while supporting clear counseling materials and medically accurate digital education.

Organizations should strengthen pharmacovigilance, invest in demand planning, and develop access partnerships with pharmacies, telehealth providers, NGOs, public health agencies, and trained clinicians. Regional strategies should be tailored to reimbursement systems, cultural context, regulatory requirements, clinician training, and procurement mechanisms rather than relying on a single global commercialization model.

Research Methodology

This executive summary is built from secondary research grounded in recognized public health and regulatory sources, including WHO, UNFPA, UNICEF, CDC, national health agencies, peer-reviewed literature, and medicine regulatory authorities. The analysis emphasizes verified indicators such as contraceptive need, method mix, access barriers, policy changes, safety guidance, and healthcare delivery trends.

Market interpretation uses triangulation across epidemiological evidence, regulatory developments, product availability, demographic patterns, clinical guidelines, and healthcare infrastructure. Insights are presented qualitatively to avoid unsupported market sizing and to maintain a data-backed, decision-useful view of the female contraceptive market.

Conclusion

The female contraceptive market is evolving through broader method choice, digital access, policy reform, and stronger expectations for safety, affordability, privacy, and equity. Opportunities exist across mature and emerging regions, but success depends on aligning products with clinical evidence, patient preferences, regulatory standards, and local access realities.

Organizations that combine reliable supply, responsible AI, evidence-based education, and region-specific partnerships will be best positioned to serve women's reproductive health needs and strengthen their role in the global family planning ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Female Contraceptive Market, by Product Type

  • 7.1. Implants
  • 7.2. Injectables
  • 7.3. Intrauterine Devices
    • 7.3.1. Copper IUD
    • 7.3.2. Hormonal IUD
  • 7.4. Pills
    • 7.4.1. Combined Pill
      • 7.4.1.1. First Generation
      • 7.4.1.2. Fourth Generation
      • 7.4.1.3. Second Generation
      • 7.4.1.4. Third Generation
    • 7.4.2. Progestin Only Pill

8. Female Contraceptive Market, by Mechanism

  • 8.1. Hormonal
    • 8.1.1. Combined
    • 8.1.2. Progestin Only
  • 8.2. Non-Hormonal

9. Female Contraceptive Market, by End User Age

  • 9.1. 15-24 Years
  • 9.2. 25-34 Years
  • 9.3. 35-49 Years

10. Female Contraceptive Market, by Distribution Channel

  • 10.1. Clinics
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Female Contraceptive Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Female Contraceptive Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Female Contraceptive Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbvie Inc.
  • 15.2. Acme Generics Pvt. Ltd.
  • 15.3. Afaxys, Inc.
  • 15.4. Agile Therapeutics, Inc.
  • 15.5. Amneal Pharmaceuticals LLC
  • 15.6. ASKA Pharmaceutical Co., Ltd.
  • 15.7. Aurobindo Pharma Limited
  • 15.8. Bayer AG
  • 15.9. Cipla Limited
  • 15.10. HLL Lifecare Limited
  • 15.11. Insud Pharma, S.L.
  • 15.12. Lupin Limited
  • 15.13. Mayne Pharma Group Limited
  • 15.14. Merck & Co., Inc.
  • 15.15. Mithra Pharmaceuticals S.A.
  • 15.16. Okamoto Industries, Inc.
  • 15.17. Organon & Co.
  • 15.18. Perrigo Company PLC
  • 15.19. Pfizer Inc.
  • 15.20. Piramal Pharma Ltd.
  • 15.21. Ritex GmbH
  • 15.22. Sanofi S.A.
  • 15.23. Say It With A Condom, LLC
  • 15.24. Syzygy Healthcare Solutions LLC
  • 15.25. Teva Pharmaceutical Industries Ltd.
  • 15.26. TherapeuticsMD, Inc.
  • 15.27. TTK Healthcare Limited
  • 15.28. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INJECTABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INJECTABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COPPER IUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COPPER IUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COPPER IUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HORMONAL IUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HORMONAL IUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HORMONAL IUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMBINED PILL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMBINED PILL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMBINED PILL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FIRST GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FIRST GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FIRST GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOURTH GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOURTH GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOURTH GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SECOND GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SECOND GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SECOND GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL THIRD GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL THIRD GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THIRD GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROGESTIN ONLY PILL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROGESTIN ONLY PILL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROGESTIN ONLY PILL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HORMONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HORMONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HORMONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMBINED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COMBINED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMBINED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PROGESTIN ONLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PROGESTIN ONLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PROGESTIN ONLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-HORMONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-HORMONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-HORMONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL 15-24 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL 15-24 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL 15-24 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL 25-34 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL 25-34 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL 25-34 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL 35-49 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL 35-49 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL 35-49 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 145. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 146. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 172. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 173. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. NATO FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 182. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 184. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 203. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 212. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 220. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 221. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 244. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 245. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 246. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 247. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 248. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 256. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 257. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 262. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 263. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 264. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 265. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 266. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 295. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 297. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 298. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 299. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 300. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 301. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 302. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 303. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 306. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 307. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 308. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)